A critical review of the role of endothelial factors in the pathogenesis of hypertension

Journal of Cardiovascular Pharmacology

Volumn 38, Issue SUPPL. 2, 2002, Pages

  Schiffrin, E L ^a  

^a NONE   (Canada)

Author keywords

Endothelin; Endothelium; Endothelium derived contracting factor; Endothelium derived hyperpolarizing factor; Nitric oxide; Oxidative stress; Oxygen free radicals

Indexed keywords

ARACHIDONIC ACID; CANNABINOID; CYTOCHROME P450; ENDOPEROXIDE; ENDOTHELIN 1; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; EPOXYICOSATRIENOIC ACID; NATRIURETIC PEPTIDE TYPE C; NITRIC OXIDE; PROSTACYCLIN; THROMBOXANE; VASOCONSTRICTOR AGENT;

BLOOD CLOTTING; BLOOD VESSEL WALL; CONFERENCE PAPER; DIABETES MELLITUS; DYSLIPIDEMIA; ENDOTHELIUM; HOMEOSTASIS; HYPERHOMOCYSTEINEMIA; HYPERTENSION; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; SMOKING;

EID: 0036136342     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200111002-00002     Document Type: Conference Paper

References (26)

1. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide
2. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
3. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors
4. Characterization of cannabinoid receptors coupled to vasorelaxation by endothelium-derived hyperpolarizing factor
5. Heme oxygenase 2: Endothelial and neuronal localization and role in endothelium-dependent relaxation
6. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
7. Impaired endothelium-dependent relaxations in hypertensive small arteries involve the cyclooxygenase pathway
8. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension
9. Angiotensin II stimulates NADH and NADPH activity in cultured vascular smooth muscle cells
10. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
11. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy
12. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
13. The loss of endothelium-dependent vascular relaxation in hypertension
14. Abnormal endothelium dependent vascular relaxation in patients with essential hypertension
15. Preserved endothelium-dependent vasodilatation in patients with essential hypertension
16. Endothelium-dependent relaxation of small arteries from essential hypertensive patients: Mechanisms and comparison with normotensive subjects and with responses of vessels from spontaneously hypertensive rats
17. Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension
18. Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients
19. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients
20. Chronic inhibition of nitric oxide synthesis: A new model of arterial hypertension
21. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat
22. Indomethacin enhances the impaired endothelium-dependent relaxations in small mesenteric arteries of the spontaneously hypertensive rat
23. Role of endothelin-1 in hypertension
24. Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension
25. Role of endothelin in the increased vascular tone of patients with essential hypertension
26. Bosentan hypertension investigators: The effect of an endothelin receptor antagonist, bosentan, on blood pressure in patients with essential hypertension